List | Section | Observation |
---|---|---|
Cayman Islands Health Services Authority Pharmacy Drug Formulary | 09.02.02.02 Plasma and Plasma Substitutes | No observations |
List | Section | Observation |
---|---|---|
Belize. National Drug Formulary | 11.01 Plasma substitutes | No observations |
List | Section | Observation |
---|---|---|
Costa Rica. Caja Costarricense de Seguro Social. 2019 | 43. Electrolitos y soluciones parenterales | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 11.3 Plasma substitutes |
This medicine has the best evidence for effectiveness and safety. |
Chile. Formulario Nacional de Medicamentos. 2005 | 10. PRODUCTOS SANGUINEOS Y SUCEDANEOS DEL PLASMA | No observations |
List | Section | Observation |
---|---|---|
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. | No observations |
List | Section | Observation |
---|---|---|
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 08.03. SUSTITUTOS Y EXPANSORES PLASMATICOS | No observations |
Guyana. Essential Medicines List. 2020-2021 | 14.01 Plasma Substitutes | No observations |
List | Section | Observation |
---|---|---|
Haiti. National List of Essential Medicines | 11.01 Plasma substitutes | No observations |